Captopril and hydrochlorotiazide
Company: Mylan Laboratories
Approval Status: Approved May 1997
Treatment for: hypertension
Areas: Cardiology/Vascular Diseases; Endocrinology
Possible similar drugs: Captopril and hydrochlorotiazide
General Information
Other Useful Resources
Captopril and hydrochlorothiazide tablets have been tentatively approved for the treatment of hypertension. Tablets will be manufactured in 25mg/15mg, 50mg/15mg, 25mg/25mg and 50mg/25mg strengths. This antihypertensive product is the generic equivalent of Bristol-Myers Squibb’s capozide. Shipment is scheduled to begin after the Dec. 27, 1997 expiration of Bristol-Myers Squibb’s patent.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
